Format

Send to

Choose Destination
J Am Soc Echocardiogr. 2018 Apr;31(4):491-504. doi: 10.1016/j.echo.2017.06.014. Epub 2017 Aug 23.

Transcatheter Tricuspid Valve-in-Valve Intervention for Degenerative Bioprosthetic Tricuspid Valve Disease.

Author information

1
Structural Heart & Valve Center, New York Presbyterian/Columbia University Medical Center, New York, New York.
2
Morristown Medical Center, Morristown, New Jersey.
3
Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California.
4
Royal Brompton Hospital, London, United Kingdom.
5
Royal Brompton Hospital, London, United Kingdom. Electronic address: a.duncan@rbht.nhs.uk.

Abstract

Isolated reoperative tricuspid valve replacement is one of the highest risk operations classified in the Society of Thoracic Surgeons registry, particularly in the setting of preexisting right ventricular dysfunction. Transcatheter tricuspid valve-in-valve implantation represents an attractive alternative to redo surgery in patients with tricuspid bioprosthetic valve degeneration who are considered high-risk or unsuitable surgical candidates. In this review article, the authors discuss the emergence of transcatheter tricuspid valve-in-valve therapy, preprocedural echocardiographic assessment of tricuspid bioprosthetic valve dysfunction, periprocedural imaging required for tricuspid valve-in-valve implantation, and postprocedural assessment of tricuspid transcatheter device function.

KEYWORDS:

Degenerative bioprosthetic tricuspid valve; Transcatheter; Tricuspid; Valve-in-valve

PMID:
28843367
DOI:
10.1016/j.echo.2017.06.014

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center